Dr. Hönle AG

EANS-Adhoc: Hönle Group achieves operating result of EUR 1.5 million in the first quarter

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Financial Figures/Balance Sheet
27.02.2013


In the first quarter of the 2012/2013 financial year, the Hönle Group sales
revenues improved from TEUR 15,773 in the previous year to TEUR 16,543 in the
current financial year. The increase was due to the consolidation of new Group
companies, among other things. Hönle improved its operating result (EBIT) in the
first three months from TEUR 829 in the previous year to TEUR 1,475 in the
current year. The pre-tax result (EBT) amounted to TEUR 1,288 after TEUR 828 in
the previous year and the consolidated net income for the year jumped to TEUR
939 after TEUR 383 in the year before, translating into earnings per share of
EUR 0.17 (PY: EUR 0.08).

The EBIT margin thus improved from 5.3 % in the previous year to 8.4 %, while
the net return on sales rose from 2.4 % to 5.7 %. Operative cash flow amounts to
TEUR 2,447 after TEUR 628 in the previous year. The Hönle Group's equity ratio
stands at 60.7 %.

Outlook:
While the Hönle Group's future business development also depends on the
development of the global economy, it is significantly impacted by the
effectiveness of the measures taken to optimise the operational and organisation
structure, in particular with respect to the new subsidiaries. The Management
aims at Hönle Group sales of between EUR 80 to 85 million in financial year
2012/2013 and an operating result of between EUR 10 and 12 million. The figures
include consolidation of Grafix GmbH for 9 months in the current financial year.

In the first quarter of the 2012/2013 financial year, Hönle felt the weak
propensity to invest in the 'equipment and systems' and the 'glass and lamps'
segments. It contributed significantly to the fact that both sales and earnings
level lagged behind expectations. From the beginning of 2013, the Hönle Group
benefitted from the pick up in economic recovery which led to rising incoming
orders and order portfolios.

The newly acquired Grafix GmbH will expand the existing product range for the
printing market. Customer loyalty of important buyers can thus be strengthened
and further improved. In addition, the customer base of Grafix GmbH can also be
used for other companies in the Hönle Group. A solid sales level and a positive
earnings contribution are already projected for the first year of the initial
consolidation of Grafix GmbH. 

As a result of its three business segments: 'Equipment and Systems', 'Adhesives'
and 'Glass and Lamps', the Hönle Group is well positioned with respect to its
further business development. Moreover, the Group is represented in markets that
still offer great potential for further growth. The objective of exceeding the
sales threshold of EUR 100 million in the foreseeable future has thus come
within close reach, which is not only due to the acquisition of Grafix GmbH.

As planned, Hönle will publish the three-month report for 2012/2013 on 28
February, 2013.

About Hönle: 
Dr. Hönle AG is a listed technology company with registered head office in
Gräfelfing near Munich. With about 500 employees, the Hönle Group is among the
leading suppliers in the UV technology segment worldwide. The equipment is used
in colour and paint drying, in adhesives and plastics hardening and in surface
sterilization and sunlight simulation. Adhesives and casting compounds for
industrial applications are another focus of activities. Moreover, the corporate
group manufactures UV beamers for water sterilization and produces tubes and
semi-finished products from fused quartz for use in various sectors of industry.
Worldwide, the Hönle Group is represented at ca. 50 locations in more than 20
countries with its own companies and distribution partners.


Further inquiry note:
Peter Weinert, phone: +49 89 85608 173, mail: peter.weinert@hoenle.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      Dr. Hönle AG
             Lochhamer Schlag  1
             D-82166 Gräfelfing/München
phone:       +49 89 85608 0
FAX:         +49 89 85608 101
mail:     peter.weinert@hoenle.de
WWW:      www.hoenle.de
sector:      Instrument Engineering
ISIN:        DE0005157101
indexes:     CDAX, Prime All Share, Technology All Share
stockmarkets: free trade: Hannover, Berlin, München, Hamburg, Düsseldorf,
             Stuttgart, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: